Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer

International Journal of Biochemistry and Cell Biology

Volumn 53, Issue , 2014, Pages 389-398

  Giannakakis, Antonis ^a,b   Karapetsas, Athanasios ^a   Dangaj, Denarda ^a,c   Lanitis, Evripidis ^a,c   Tanyi, Janos ^d   Coukos, George ^e   Sandaltzopoulos, Raphael ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

CXCL9; Early ovarian cancer; SMARCE1; Termination transcription factor 1

Indexed keywords

CXCL9 CHEMOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; RANTES; CXCL9 PROTEIN, HUMAN; DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCE1 PROTEIN, HUMAN; TTF1 PROTEIN, HUMAN;

ARTICLE; CANCER STAGING; CD8+ T LYMPHOCYTE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINE RELEASE; FEMALE; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; OVARY CANCER; POLYMERASE CHAIN REACTION; RNA GENE; SMARCE1 GENE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHEMOKINE CXCL9; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 84903266195     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.05.031     Document Type: Article

References (36)

1. reg) cells are associated with a metastatic phenotype Gynecol Oncol 116 2010 556 562
2. E. Battaglioli, M.E. Andrés, D.W. Rose, J.G. Chenoweth, M.G. Rosenfeld, and M.E. Anderson et al. REST repression of neuronal genes requires components of the hSWI-SNF complex J Biol Chem 277 2002 41038 41045 (Pubitemid 35215694)
3. B. Belandia, R.L. Orford, H.C. Hurst, and M.G. Parker Targeting SWI/SNF chromatin remodelling complexes to estrogen-responsive genes EMBO J 21 15 2002 4094 4103 (Pubitemid 34857441)
4. M.J. Callahan, Z. Nagymanyoki, T. Bonome, M.E. Johnson, B. Litkouhi, and E.H. Sullivan et al. Increased HLA-DMB expression in the tumor epithelium is associated with increased cytotoxic T lymphocyte infiltration and improved prognosis in advanced serous ovarian cancer Clin Cancer Res 14 23 2008 7667 7673
5. T.H. Chi, M. Wan, K. Zhao, I. Taniuchi, L. Chen, and D.R. Littman et al. Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes Nature 418 2002 195 199 (Pubitemid 34773775)
6. B. Clarke, A.V. Tinker, C.H. Lee, S. Subramanian, M. van de Rijn, and D. Turbin et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss Mod Pathol 22 2009 393 402
7. C.G. Clemente, M.C. Mihm Jr., R. Bufalino, S. Zurrida, P. Collini, and N. Cascinelli Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer 77 1996 1303 1310 (Pubitemid 26102328)
8. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, and P. Mottram et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 9 2004 942 949 (Pubitemid 39273735)
9. G. Dennis Jr., B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, and H.C. Lane et al. DAVID: database for annotation, visualization and integrated discovery Genome Biol 4 2003 P3
10. J.M. Farber Mig and IP-10. CXC chemokines that target lymphocytes J Leukoc Biol 61 1997 246 257 (Pubitemid 27149903)
11. J.K. Gerber, E. Gögel, C. Berger, M. Wallisch, F. Müller, and I. Grummt et al. Termination of mammalian rDNA replication: polar arrest of replication fork movement by transcription termination factor TTF-I Cell 90 1997 559 567 (Pubitemid 27347245)
12. I. Grummt, U. Maier, A. Ohrlein, N. Hassouna, and J.P. Bachellerie Transcription of mouse rDNA terminates downstream of the 3′ end of 28S RNA and involves interaction of factors with repeated sequences in the 3′ spacer Cell 45 1985 801 810
13. I. Grummt, H. Rosenbauer, I. Niedermeyer, U. Maier, and A. Ohrlein A repeated 18 bp sequence motif in the mouse rDNA spacer mediates binding of a nuclear factor and transcription termination Cell 45 1986 837 846
14. J. Hamanishi, M. Mandai, M. Iwasaki, T. Okazaki, Y. Tanaka, and K. Yamaguchi et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer Proc Natl Acad Sci USA 104 2007 3360 3365 (Pubitemid 46364164)
15. A.P.M. Heinz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, and W.T. Creasman et al. Carcinoma of the ovary, FIGO 6th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 2006 s191 s192
16. W. Hung da, B.T. Shermann, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
17. W.T. Hwang, S.F. Adams, E. Tahirovic, I.S. Hagemann, and G. Coukos Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis Gynecol Oncol 124 2012 192 198
18. B. Kornmann, N. Preitner, D. Rifat, F. Fleury-Olela, and U. Schibler Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs Nucleic Acids Res 29 11 2001 E51
19. I. Kryczek, M. Banerjee, P. Cheng, L. Vatan, W. Szeliga, and S. Wei et al. Phenotype, distribution, generation and functional and clinical relevance of Th17 cells in the human tumor microenvironments Blood 114 2009 1141 1149
20. G. Längst, P.B. Becker, and I. Grummt TTF-I determines the chromatin architecture of the active rDNA promoter EMBO J 17 1998 3135 3145 (Pubitemid 28254385)
21. G. Längst, T.A. Blank, P.B. Becker, and I. Grummt RNA polymerase I transcription on nucleosomal templates: the transcription termination factor TTF-I induces chromatin remodeling and relieves transcriptional repression EMBO J 1997 760 816
22. N. Leffers, M.J.M. Gooden, R.A. de Jong, B.N. Hoogeboom, K.A. ten Hoor, and H. Hollema et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer Cancer Immunol Immunother 58 2009 449 459
23. N. Leffers, R.S.N. Fehrmann, M.J.M. Gooden, U.R.J. Schulze, K.A. ten Hoor, and H. Hollema et al. Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer Br J Cancer 103 2010 685 692
24. F. Liao, R.L. Rabin, J.R. Yanelli, L.G. Koniaris, P. Vanguri, and J.M. Farber Human Mig chemokine: biochemical and functional characterization J Exp Med 182 1995 1301
25. K.A. Link, C.J. Burd, E. Williams, T. Marshall, G. Rosson, and E. Henry et al. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF Mol Cell Biol 25 6 2005 2200 2215 (Pubitemid 40354619)
26. Y. Naito, K. Saito, K. Shiiba, A. Ohuchi, K. Saigenji, and H. Nagura et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 1998 3491 3494 (Pubitemid 28376536)
27. E. Sato, S.H. Olson, J. Ahn, B. Bundy, H. Nishikawa, and F. Qian et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favourable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 2005 18538 18543 (Pubitemid 43011261)
28. K. Schumacher, W. Haensch, C. Roefzaad, and P.M. Schlag Prognostic significance of activated CD8(+) T cell infiltration within esophageal carcinomas Cancer Res 61 2001 3932 3936 (Pubitemid 32720953)
29. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics 2013 CA Cancer J Clin 63 2013 11 30
30. M. Tomšová, B. Melichar, I. Sedláková, and I. Šteiner Prognostic significance of CD3+ tumor infiltrating lymphocytes in ovarian carcinoma Gynecol Oncol 18 2008 415 420 (Pubitemid 351174290)
31. T.C. Walser, X. Ma, N. Kundu, R. Dorsey, O. Goloubeva, and A.M. Fulton Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model J Immunother 30 2007 490 498 (Pubitemid 46988082)
32. M. Wan, J. Zhang, D. Lai, A. Jani, P. Prestone-Hurlburt, and L. Zhao et al. Molecular basis of CD4 repression by the SWI/SNF-like BAF chromatin remodelling complex Eur J Immunol 39 2 2009 580 588
33. W. Wang, J. Cote, Y. Xue, S. Zhou, P.A. Khavari, and S.R. Biggar et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex EMBO J 15 1996 5370 5382 (Pubitemid 26336219)
34. L. Wang, R.A. Baiocchi, S. Pal, G. Mosialos, M. Caligiuri, and S. Sif The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene Mol Cell Biol 25 28 2005 7953 7965 (Pubitemid 41262990)
35. W. Wang, T. Chi, Y. Xue, S. Zhou, A. Kuo, and G.R. Crabtree Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF related complexes Proc Natl Acad Sci USA 95 1998 492 498 (Pubitemid 28083770)
36. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, and G. Regnani et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 2003 203 213 (Pubitemid 36077915)